Lupus Capital PLC
23 February 2004
Lupus Capital Plc
Board appointment
Lupus Capital plc announced today the appointment of Denis Mulhall as an
Executive Director. He will join the Company and Board with immediate effect.
From 1988 to 1993 Denis, 52, worked with Greg at Tomkins, the company Greg built
from a market capitalisation of £6m to £5bn in 15 years. Denis left to join
Berisford plc firstly as Chief Financial Officer and then Chief Operating
Officer, seeing the transformation of the company from a shell to a market
capitalisation of £700m. Recently he was Chief Financial Officer at Oxford
GlycoSciences Plc.
Commenting on the appointment, Greg Hutchings said: 'We are now building the
core team of the company which will see us through to the first series of
acquisitions. This is a very exciting and important time for Lupus and I am
looking forward to a year of great progress.'
Commenting on his appointment Denis Mulhall said: 'I am delighted to be working
with Greg again. We proved what can be achieved at Tomkins where under Greg's
leadership massive shareholder value was created.'
Enquiries:
Equity Development 020 7405 7777 / 07850 944187
Alan Frame
Mr. Mulhall is a non-executive director of RingProp plc. In accordance with
paragraph 16.4 of the Listing Rules, no further details regarding Mr. Mulhall
are required to be disclosed under paragraph 6.F.2(b) to (g).
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.